Diabetes Information

Benfotiamine - A New Tool In Preventing Diabetic Complications?


Benfotiamine made headlines globally in 2003 when researchers released information about a study that was conducted at The Einstein College of Medicine in New York. The bottom line of this study was that a substance of the allithiamine group of the naturally occurring thiamine-derived compounds had positive effects on neuropathy, retinopathy and nephropathy and heart/circulatory problems in diabetics.

Benfotiamine research has suggested that there are beneficial effects for diabetics and non-diabetics also. These benefits include sciatica, vascular health, general nerve health, lower blood pressure, grant cellular protection, anti-aging, fibromyalgia, prevention of lactic acidosis, and treatment for Alzheimer's disease. Any condition that is the result of a thiamine deficiency will also respond quite well to benfotiamine. Of course, any bodily function that is improved by a therapeutic level of thiamine will certainly be enhanced by benfotiamine, since benfotiamine is perhaps the most effective form of thiamine.

Benfotiamine, a derivative of thiamine (vitamin B1), was an invention of Japanese scientists and there is a U.S. patent on benfotiamine that was entered by the Japanese back in 1962. Japanese benfotiamine is considered the purest source of bulk benfotiamine and is favored by manufacturers globally who insist on the highest quality in their benfotiamine product.

The safety of benfotiamine use has been proven over 12 years of use in Europe for the treatment and prevention of diabetic complications among others. The original Japanese patent on benfotiamine gave information that it is even less toxic than common vitamin B1 (thiamine hydrochloride usually). Orally ingested vitamin B1 has a long history of use as an oral supplement without reported adverse effects. Due to its therapeutic action in some frequently observed clinical syndromes, thiamine hydrochloride has been advised and used over a long period of time. There are no reports of adverse effects of oral thiamine, even at dosages of several hundred milligrams a day (SCOGS, 1978; DHEW, 1979; Marks, 1989).

Benfotiamine has a very good safety record. To date, there has been no reports of any known, negative interactions with any medications. To the contrary, some medications actually can cause a thiamine deficiency in some people and benfotiamine could correct this serious situation.

Many researchers, medical experts, doctors, podiatrists and many medical publishers recommend benfotiamine for neuropathy, retinopathy nephropathy, heart/circulatory complications and B1 deficiencies. Any in depth study on the web will produce physicians, naturopaths, neurologists, optometrists, chiropractors, etc. who have very positive feelings about the effectiveness and potential of benfotiamine in terms of the research done to date on this important tool in the arsenal against neuropathy, retinopathy and beneficial for the heart and circulatory system. We have professional healthcare providers from all of these disciplines which shows the confidence the medical community has in the purity and bioavailability of our benfotiamine product.

Dr. David Williams, publisher of "Alternatives Newsletter", wrote an in depth article concerning benfotiamine in his May, 2004 issue. This article is an eye opener in terms of how effective benfotiamine can be for many health conditions. If possible, it would be beneficial for any interested reader to take a look at this article. For more information about this article you may contact the author below.

Dr Paul Chous is another medical professional who sees the merits of benfotiamine:

"I suspect strongly that benfotiamine will mitigate (or, hopefully, prevent) DRT in humans, but the burden of proof has not yet been met. The case for symptomatic relief of neuropathy symptoms is, of course, more tangible." http://www.emuhealthproducts.com/drchous.html

In conclusion, the consensus for benfotiamine is very positive and are worth investigating. If you or anyone you know is a diabetic, the great possibility of developing diabetic complications over time makes benfotiamine a viable tool in the arsenal for protection. If they are already experiencing complications such as neuropathy, retinopathy, and others, they will benefit from possible reduction in the progression along with pain relief in terms of peripheral neuropathy and other neuropathies.

Zach Malott is CEO of Brentwood Health International, a nutritional supplement company involved in distribution and supplying wholesale, retail and end users.

Mr. Malott is available to discuss the research as it applies to benfotiamine in the treatment and prevention of diabetic complications such as neuropathy and retinopathy.

He can be reached at:

Phone: 505.354.0526

Website: http://www.emuhealthproducts.com


MORE RESOURCES:

CBC.ca

Jets Owner's Daughter Died of a Complication of Diabetes
New York Times
By AP LOS ANGELES (AP) — Casey Johnson, a daughter of the Jets' owner, Woody Johnson, died of a complication of diabetes, the Los Angeles County coroner ...
Casey Johnson died of diabetes-related condition, LA County coroner saysLos Angeles Times
Casey Johnson Died from Diabetes-Related Condition, Coroner SaysSeattle Post Intelligencer
Coroner: Casey Johnson's death diabetes relatedNewsday (subscription)
msnbc.com -The Star-Ledger - NJ.com -RTT News
all 731 news articles »


Co-op Offers Diabetes Management Course
WMBB-TV
The University of Florida/ IFAS Bay County Extension Office is conducting a series of classes to help people with Type 2 diabetes control their blood sugar. ...

and more »


The Herald

Weighing up diabetes risk
Irish Times
COULD YOU be one of the thousands of people in Ireland on the brink of developing type 2 diabetes? Would you even know if you already had the condition? ...
Diabetes scare as three kids taken to A&E each weekBelfast Telegraph
Get Serious on diabetesDerry Today
Child diabetes emergency hospital admissions cause concernDiabetes.co.uk
WebMD.Boots.com -BBC News -HULIQ
all 46 news articles »


Avandia Heart Attack Risk Twice as High as Other Diabetes Drugs: Study
AboutLawsuits.com
The results of a new study indicate that side effects of Avandia may double the risk of heart attacks when compared to other diabetes drugs. ...
Avandia Information and Support Center Announces Launch of Avandia-Injury ...PR Web (press release)

all 2 news articles »


XOMA Initiates Phase 2b Dose-Ranging Clinical Trial of XOMA 052 in Type 2 ...
MarketWatch
Type 2 diabetes patients enrolled in the trial will be on stable metformin therapy and will receive monthly treatment for six months with one of four doses ...

and more »


Where You Live, Not Just Lifestyle, May Contribute To Diabetes
WBUR
BOSTON — A new study finds that black women in poor neighborhoods are at higher risk for diabetes regardless of how well-educated they are ...
Prosperity and type 2 diabetes risk linkedDiabetes.co.uk
Researchers Find Link Between Neighborhood Socioeconomic Status And Diabetes RiskHealthcanal.com

all 4 news articles »


CBS News

Obama sets up task force on childhood obesity
CNN
About one-third of Americans born in the year 2000 or later will suffer from diabetes at some point in their lifetime, according to the memo. ...
Obesity focus vital crusadeScranton Times-Tribune
Michelle Obama kicks off drive against childhood obesityAFP
Gillibrand helps kick off campaign to fight childhood obesity todayMPNnow.com
Los Angeles Times (blog) -USA Today -Huffington Post (blog)
all 626 news articles »


Marion Regional Healthcare System sponsoring diabetes programs
South Carolina Now
Each year in the United States approximately 1.6 million new cases of diabetes are diagnosed in people 20 years or older, bringing the ...

and more »


CBC.ca

Insulin Study Could Lead to New Dosage Devices
New York Times
The results of a new study on managing juvenile diabetes may give hope to millions of parents in this country and abroad who typically ...
Oprah Winfrey takes on a killer: type 2 diabetesUSA Today
Walgreen's free diabetes testing starts FridayChicago Tribune
Artificial pancreas tested in kids with diabetesCBC.ca
ABC News -dBTechno -Chicago Sun-Times
all 359 news articles »


BBC News

More young diabetics in Wales need sight-saving action
BBC News
Surgeons in Wales are having to give sight-saving treatment to patients in their late teens and 20s struggling to control their diabetes. ...
Diabetic Retinopathy on the Rise in WalesA Sweet Life (blog)

all 3 news articles »

Google News

home | site map
© 2006